Active substance
Results for the substance bivalirudin
1 result
About this active substance
Bivalirudin is an anticoagulant used to prevent blood clot formation during certain cardiac procedures, such as coronary angioplasty. It is a direct thrombin inhibitor that blocks the activity of this enzyme involved in blood clotting.
The medication is administered intravenously under strict medical supervision, usually during interventional procedures. The dosage is adjusted based on the patient's weight and clinical condition.
Common side effects include bleeding at the injection site, nausea, and headaches. In rare cases, severe allergic reactions or uncontrolled bleeding may occur, which is why patients must be closely monitored.
Bivalirudin is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other anticoagulant medications or medical conditions before administration.
The medication is administered intravenously under strict medical supervision, usually during interventional procedures. The dosage is adjusted based on the patient's weight and clinical condition.
Common side effects include bleeding at the injection site, nausea, and headaches. In rare cases, severe allergic reactions or uncontrolled bleeding may occur, which is why patients must be closely monitored.
Bivalirudin is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other anticoagulant medications or medical conditions before administration.